Mogrify
Mogrify is developing tailored cellular conversions that power future cell therapies.
8
Funding Rounds
$84.5m
Money raised
Funding
Funding series
Funding Series Analysis
The company Mogrify has raised a total of $46.7m in funding over 8 rounds.
Key Insights:
- Mogrify October 2023 Series A Funding Round: $10m
- Mogrify May 2021 Series A Funding Round: $17m
- Mogrify October 2019 Series A Funding Round: $16m
- Mogrify February 2019 Seed Funding Round: $3.7m
- Mogrify Ltd funding round, October 2019: $16m
- Mogrify Venture round, January 2020: $1.1m
- Mogrify Series A round, May 2021: $17m
- Mogrify Seed round, February 2019: $3.7m
Mogrify October 2023 Series A Funding Round
$10m
Mogrify May 2021 Series A Funding Round
$17m
Mogrify October 2019 Series A Funding Round
$16m
Mogrify February 2019 Seed Funding Round
$3.7m
Mogrify Ltd funding round, October 2019
$16m
Mogrify Venture round, January 2020
$1.1m
Mogrify Series A round, May 2021
$17m
Mogrify Seed round, February 2019
$3.7m
Industries
Mogrify is active in the following industries:
- Cell therapy
- Arthritis
- Autoimmune disease
- Biomedical engineering
- Engineering
- Drug discovery
- Technology
- Biotechnology
- Biology
- Healthcare
- Regenerative medicine
- Immunotherapy
- Health technology
- Deep Tech